Hungary Preventive healthcare and health literacy are core issues in Hungary that, if left unaddressed, may hinder the country’s ability to push its health agenda forward and create a more sustainable system. According to the OECD, life expectancy at birth in Hungary was 75.6 years in 2014, well below the…
Czech Republic Women’s health is an increasingly significant niche for pharma companies operating in the Czech Republic, with large areas of unmet need and opportunities for growth. We have great expectations [because] fertility as a therapeutic area is the one in which I identify the largest potential for the future Rene…
Healthcare In part two of a two-part interview (read part one here), Mikel Arriola of the IMSS discusses the strategic roadmap IMSS will follow under his tenure with regards to innovation access and chronic disease prevention, as well as his approach to the upcoming implementation of exchanges of services among the…
Healthcare In part one of a two-part interview (read part two here), Mikel Arriola, the recently appointed general director of IMSS (Mexican Social Security Institute), which provides health-related services to more than 70 million beneficiaries, reveals his fundamental priorities to both secure IMSS’ financial sustainability and improve the quality of services…
Pharma Digitalization, a hot topic throughout the healthcare and life sciences industry, is having a major effect in Italy through more personalized home care for patients, allowing the government to cut costs, and enabling greater public access to innovative medical technologies. Telemedicine, a key differentiator in tender processes, is not yet used…
Pharma Dr. Teresa Corona Vázquez, the general director of one of the leading neuroscience institutions in Latin America, details their most important research partnerships and achievements, notably with regards to neurodegenerative diseases, and her expectations of fostering a heightened research-based relationship with the pharmaceutical industry. What have been some of the…
Pharma Leading in some areas, lagging in others, the Italian healthcare logistics sector is on the brink of change according to UPS Healthcare’s managing director for Italy, Jaap Heukers. Each country has slightly different interpretations of certain regulations and compliance, given their unique regulatory development path. Coming from a global international…
Pharma Juan Fransisco Millán Sobaranes of Cetifarma, the council created by the pharmaceutical industry in Mexico for ethics and transparency, discussed the agency’s major milestones and its main priorities for ensuring transparency, notably with regards to patient groups, healthcare practitioners, and clinical trials. You were part of the initial team…
Pharma Mohammad Afshar, CEO of Ariana Pharma, shares his insights on the importance of decision support tools, big data’s impact on the healthcare industry, and the need to translate this data into the production of real products. He also discusses the challenges he faced as an entrepreneur in France and his…
Health The director of the Institute of Health Information and Statistics in the Czech Republic explains his mandate to implement a national health information system and reviews its potential impact. He also identifies how his work will help solve the challenges in the current healthcare system and bring quality healthcare to patients.…
Pharma The following statistics provide an overview of South Africa’s healthcare environment, including population, life expectancy, ten leading causes of death, and healthcare expenditure. Click here to read more articles and interviews from South Africa, and to download the latest free pharma report on the country.
Healthcare The President of the Doctoral Council of Semmelweis University, Dr. József Timár provides an overview of the healthcare system in Hungary with particular reference to oncology and describes the challenges and prospects of medical innovation in the country. Can you please provide an insight into the history and presence of…
See our Cookie Privacy Policy Here
